Basilea Pharmaceutica AG

SIX:BSLN.SW

45.8 (CHF) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Operating Activities:
Net Income 10.45112.147-6.831-14.722-22.422-31.352-19.36-51.287-61.603-41.546-33.02-53.033-57.646107.564-120.736-143.528-126.82-85.15-49.596-75.472-55.651-58.973
Depreciation & Amortization 3.4773.0972.4542.291.6391.7521.8912.2192.3272.2912.7153.6422.8764.0334.9534.1222.7042.9653.5694.5314.7523.371
Deferred Income Tax -4.775-19.093-45.423-8.451-3.638-8.095-2.299-0.073-4.125-3.803-6.967-0.4820000-0.013-0.036-0.142000
Stock Based Compensation 4.7623.5984.3223.5253.0486.34.6218.0259.35.9213.35.09010.1630013.6599.9913.975000
Change In Working Capital -4.317-11.723-31.787-30.762-46.8591.795-2.322-7.952-5.175-2.1183.667187.867-28.675-14.5183.527-5.20632.1820.14876.7664.329-1.853-8.464
Accounts Receivables 3.4512.587-32.064-4.1226.4521.054-2.277-1.097-0.3832.7313.66700000000000
Inventory -2.166-1.461-1.591-2.618-4.1420.741-0.045-6.855-4.792-4.84903.8290.202-3.894-0.09-0.056000000
Accounts Payables 5.656-10.427-2.5386.3940.3782.0512.50.764-1.0160000000000000
Other Working Capital -11.258-2.4224.406-30.416-49.547-2.051-2.5-0.7641.016-7.9142.735184.038-28.877-10.6243.616-5.15000000
Other Non Cash Items 4.64719.0345.245-6.0144.396-49.6134.184-26.008-12.629-36.009-36.1335.091.068-0.606-2.25317.446-0.7-0.384-0.1932.4080.3280
Operating Cash Flow 14.2457.056-32.02-54.134-63.836-79.2119.014-75.003-67.78-71.461-59.47148.174-82.377106.636-114.51-127.166-78.988-72.46534.38-64.204-52.424-64.066
Investing Activities:
Investments In Property Plant And Equipment -1.034-3.303-0.86-2.265-0.404-0.419-0.711-0.394-1.009-1.247-1.103-1.321-3.525-1.239-1.761-5.218-6.531-1.625-1.201-0.44-4.442-22.718
Acquisitions Net 00-1.58818.3250.1100.0050.0070.009-8535-0.214-0.464-0.191-1.140000000
Purchases Of Investments 00-35-81.023-500-60-50-81.6-90-155-200-25-250-1000-500-215-226.5-13500
Sales Maturities Of Investments 094.95141.02330506059.99551.6351001751201051501652500385275162.75069.7579
Other Investing Activites -0.2210.0010.015-33.14-0.11-0.19-0.234-0.037-0.303-0.059-0.0870.220.4680.1991.14440.0050.0190.0530.1880.2630.0520
Investing Cash Flow -1.03491.6493.575-34.963-0.40459.391-60.941.21117.09783.694-36.189-96.315121.479-86.231148.24334.787-121.51258.428-64.763-135.17765.3656.282
Financing Activities:
Debt Repayment -59.314-73.875-23.212-40.2580000-194.6870000000-0.0020-10.3850-0.42-0.299
Common Stock Issued 2.4814.42644.1064.8091.3090.2492.6310.41113.37624.8638.50.0010.0420.1160.861.802333.92721.0723.327192.78520.710
Common Stock Repurchased -0.4720-4.25400-6.2350000000000000-0.20100
Dividends Paid 0000000000-47.95500000000000
Other Financing Activities 57.30524.20323.21280.5161.3090.2492.6310.41113.376-038.500-0.005-0.007-0.007000-0.483010
Financing Cash Flow -57.305-45.24616.6445.0671.309-5.9862.6310.411208.06324.86-9.4550.0010.0420.1110.8531.795333.92521.072-7.058192.120.299.701
Other Information:
Effect Of Forex Changes On Cash -0.1510.1550.501-0.7580.067-1.0110.989-0.653-0.4410.1340.056-0.0510.013-0.9040.162-0.605-0.199-0.0770.157-0.1-0.066-0.178
Net Change In Cash -24.078-18.386-0.6541.08716.212-26.816-38.306-74.034156.93937.227-105.05851.80939.15719.61134.748-91.189133.2266.958-37.283-7.38133.161.739
Cash At End Of Period 12.48936.56754.95355.60754.52173.908200.724239.03313.064156.125118.898223.955172.146132.989113.37878.63169.81936.59329.63566.91874.29941.139